KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Change in Acquisitions & Divestments: 2014-2024

Historic Change in Acquisitions & Divestments for BeOne Medicines (ONC) over the last 11 years, with Dec 2024 value amounting to $2.7 million.

  • BeOne Medicines' Change in Acquisitions & Divestments fell 32.20% to $1.8 million in Q1 2025 from the same period last year, while for Mar 2025 it was $110.2 million, marking a year-over-year decrease of 63.14%. This contributed to the annual value of $2.7 million for FY2024, which is 99.61% down from last year.
  • Latest data reveals that BeOne Medicines reported Change in Acquisitions & Divestments of $2.7 million as of FY2024, which was down 99.61% from $673.2 million recorded in FY2023.
  • In the past 5 years, BeOne Medicines' Change in Acquisitions & Divestments registered a high of $2.8 billion during FY2021, and its lowest value of $2.7 million during FY2024.
  • Moreover, its 3-year median value for Change in Acquisitions & Divestments was $673.2 million (2023), whereas its average is $746.5 million.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first soared by 46.17% in 2020, then plummeted by 99.61% in 2024.
  • Over the past 5 years, BeOne Medicines' Change in Acquisitions & Divestments (Yearly) stood at $2.8 billion in 2020, then grew by 0.27% to $2.8 billion in 2021, then slumped by 43.31% to $1.6 billion in 2022, then tumbled by 56.94% to $673.2 million in 2023, then slumped by 99.61% to $2.7 million in 2024.